News
Changes to the project registry of swissethics
24.09.2019
Since 2016, swissethics has regularly published clinical trials and research projects that have been approved by the competent ethics committees in Switzerland. The focus was on "ongoing" clinical trials and research projects (RoPS, Registry of ongoing projects in Switzerland).
From now on, all clinical trials/projects will be published. Consequently, those that have already been completed can also be found in the register. Thus, the registry has been renamed RAPS: Registry of All Projects in Switzerland
Position paper of swissethics on how to manage incidental findings in medical research
06.08.2019
Im Rahmen der Humanforschung gibt es durch Diagnostik und Untersuchungen in einem nicht unerheblichen Prozentsatz im Rahmen von klinischen Studien und Projekten Zufallsbefunde.
Read moreUpdated Guidance for providers of courses on Research Ethics and GCP: new including GCP Refresher courses
06.08.2019
Since 1 January 2014, GCP course providers can have their GCP courses for investigators and sponsor-investigators in Switzerland recognised by swissethics.
Read moreImportant remarks on the information on the "Temporary authorisation to use medicinal products in accordance with Article 9b paragraph 1 HMG" of 13.3.2019
10.04.2019
The information published by swissethics on 13.3.2019 is aimed at pharmaceutical companies, i.e. sponsors who can apply for a temporary authorisation for their drug under certain conditions.
Read moreThe total revision of the Ordinance on the Authorisation of Medicinal Products (AMBV) entered into force on 1st January 2019.
13.03.2019
AMBV Chapter 5 regulates the temporary authorisation for the use of medicinal products in accordance with Art. 9b Para. 1 TPA. The procedures formerly known as "compassionate use" (now temporary authorisation) refer to therapeutic products whose efficacy has already been proven in clinical trials.
Read more